Oseltamivir pharmacokinetics in morbid obesity (OPTIMO trial).
about
The pharmacological management of severe influenza infection - 'existing and emerging therapies'.Pharmacokinetics of orally administered oseltamivir in healthy obese and nonobese Thai subjects.Obesity and the risk and outcome of infection.The use of antiviral drugs for influenza: Guidance for practitioners 2012/2013Population pharmacokinetics of oseltamivir and oseltamivir carboxylate in obese and non-obese volunteers.Pharmacokinetic properties of anti-influenza neuraminidase inhibitors.Interaction of obesity and infections.Population pharmacokinetic analysis of oseltamivir and oseltamivir carboxylate following intravenous and oral administration to patients with and without renal impairment.
P2860
Q30243907-7F1DC612-BC40-47FF-80D5-E54E82B5BAE2Q30357189-BDB349A7-68B6-4487-8916-1E262627BEAAQ30416191-0DE49287-571B-47CD-929E-115235A3D9D1Q34389114-B28AC86B-61FD-40F9-9775-FC9CC7FC2FC4Q36924693-7AEEF16D-B490-4AFD-8246-C013432310D7Q38084212-6B1A9799-C13A-488C-B2EE-814504545D18Q38583848-9FBB1C4C-C4C0-476A-B9AD-7A577863DA4EQ41143036-FDDF22D1-F93D-40B1-B528-790534BACA5A
P2860
Oseltamivir pharmacokinetics in morbid obesity (OPTIMO trial).
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Oseltamivir pharmacokinetics in morbid obesity (OPTIMO trial).
@en
Oseltamivir pharmacokinetics in morbid obesity
@nl
type
label
Oseltamivir pharmacokinetics in morbid obesity (OPTIMO trial).
@en
Oseltamivir pharmacokinetics in morbid obesity
@nl
prefLabel
Oseltamivir pharmacokinetics in morbid obesity (OPTIMO trial).
@en
Oseltamivir pharmacokinetics in morbid obesity
@nl
P2093
P356
P1476
Oseltamivir pharmacokinetics in morbid obesity (OPTIMO trial).
@en
P2093
2009 OPTIMO Study Group
B L Johnston
K B Goralski
K L Slayter
L M Thorne-Humphrey
S A McNeil
T F Hatchette
P304
P356
10.1093/JAC/DKR257
P407
P577
2011-06-23T00:00:00Z